Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...
A Chinese research team recently constructed the first normative references of brain structure across the entire lifespan for ...
Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback